Clinical trial
Chemotherapy for Patients With Non-Small Cell Lung Cancer Who Are Non-Smokers
NCT00409006 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00409006 |
|---|---|
| Title | Chemotherapy for Patients With Non-Small Cell Lung Cancer Who Are Non-Smokers |
| Official title | A Phase 2 Trial of Pemetrexed and Cisplatin Followed Sequentially by Gefitinib Versus Pemetrexed and Cisplatin in Asian "Never Smoker" Patients With Advanced Non-Small Cell Lung Cancer |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Pemetrexed, Cisplatin, Gefitinib |
| Enrollment | 70 |
| Start date | Feb 1, 2007 |
| Primary completion | Aug 1, 2009 |
| Completion | May 1, 2010 |
| First posted | Dec 8, 2006 |
| Last update posted | Sep 9, 2010 |
| Countries | China, South Korea, Taiwan |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: